Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Buprenorphine vs IV Morphine for Acute Fracture Pain
NCT01298297Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of buprenorphine extended-release injection in acute pain (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Change in pain severity/score. Started Feb 2010; status: completed.
02
Drugs
buprenorphine extended-release injection
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT01298297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01298297.